LCTX Lineage Cell Therapeutics, Inc.
NYSE · SEC CIK 876343 · EDGAR
- Bought, last 12 months
- $24.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 98 since 2021-07-01, latest 2026-07-02 17:33
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Culley Brian M | Pres, CEO, Dir | $24.4K | — |
| Samuel George A. III | GC, Sec | — | — |
Transactions 51
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | 2026-03-12 | LCTX | Culley Brian M | Pres, CEO, Dir | P - Purchase | $1.63 | +15.0K | 255.5K | +6% | +$24.4K | |
| D | 2026-02-13 | 2026-02-11 | LCTX | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +31.2K | 253.4K | +14% | — |
| D | 2026-02-13 | 2026-02-11 | LCTX | Culley Brian M | Pres, CEO, Dir | F - Tax | $1.80 | -12.9K | 240.5K | -5% | -$23.2K |
| D | 2026-02-13 | 2026-02-11 | LCTX | Samuel George A. III | GC, Sec | M - OptEx | — | +6,075 | 33.6K | +22% | — |
| D | 2026-02-13 | 2026-02-11 | LCTX | Samuel George A. III | GC, Sec | F - Tax | $1.80 | -2,502 | 31.1K | -7% | -$4,504 |
| 2025-12-19 | 2025-12-19 | LCTX | Culley Brian M | Pres, CEO, Dir | A - Grant | — | +8,925 | 222.5K | +4% | — | |
| 2025-12-19 | 2025-12-19 | LCTX | Culley Brian M | Pres, CEO, Dir | F - Tax | $1.68 | -334 | 222.1K | -0.2% | -$561.12 | |
| 2025-12-19 | 2025-12-19 | LCTX | Samuel George A. III | GC, Sec | A - Grant | — | +1,735 | 27.6K | +7% | — | |
| 2025-12-19 | 2025-12-19 | LCTX | Samuel George A. III | GC, Sec | F - Tax | $1.68 | -65 | 27.5K | -0.2% | -$109.20 | |
| D | 2025-02-12 | 2025-02-11 | LCTX | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +31.2K | 226.1K | +16% | — |
| D | 2025-02-12 | 2025-02-11 | LCTX | Culley Brian M | Pres, CEO, Dir | F - Tax | $0.65 | -12.5K | 213.5K | -6% | -$8,156 |
| D | 2025-02-12 | 2025-02-11 | LCTX | Samuel George A. III | GC | M - OptEx | — | +6,076 | 28.3K | +27% | — |
| D | 2025-02-12 | 2025-02-11 | LCTX | Samuel George A. III | GC | F - Tax | $0.65 | -2,440 | 25.8K | -9% | -$1,586 |
| D | 2025-01-28 | 2025-01-27 | LCTX | BROADWOOD CAPITAL INC | 10% | P - Purchase | $0.76 | +7.89M | 49.56M | +19% | +$6.00M |
| DI | 2025-01-28 | 2025-01-27 | LCTX | BROADWOOD CAPITAL INC | 10% | P - Purchase | — | 0 | 49.56M | New | — |
| 2024-11-26 | 2024-11-26 | LCTX | Samuel George A. III | GC | P - Purchase | $0.6 | +15.0K | 22.2K | +209% | +$9,000 | |
| 2024-11-26 | 2024-11-26 | LCTX | Howe Jill Ann | CFO | P - Purchase | $0.59 | +15.0K | 25.5K | +143% | +$8,850 | |
| 2024-11-25 | 2024-11-22 | LCTX | Mulroy Michael H. | Dir | P - Purchase | $0.57 | +40.0K | 298.6K | +15% | +$22.8K | |
| 2024-11-22 | 2024-11-21 | LCTX | Culley Brian M | Pres, CEO, Dir | P - Purchase | $0.6 | +40.0K | 194.8K | +26% | +$24.0K | |
| 2024-08-19 | 2024-08-16 | LCTX | Howe Jill Ann | CFO | P - Purchase | $0.89 | +10.5K | 10.5K | New | +$9,345 | |
| 2024-05-28 | 2024-05-24 | LCTX | Culley Brian M | Pres, CEO, Dir | P - Purchase | $1.05 | +10.0K | 154.8K | +7% | +$10.5K | |
| D | 2024-02-12 | 2024-02-11 | LCTX | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +31.2K | 157.6K | +25% | — |
| D | 2024-02-12 | 2024-02-11 | LCTX | Culley Brian M | Pres, CEO, Dir | F - Tax | $1.08 | -12.8K | 144.8K | -8% | -$13.8K |
| D | 2024-02-12 | 2024-02-11 | LCTX | Samuel George A. III | GC, Sec | M - OptEx | — | +6,076 | 9,674 | +169% | — |
| D | 2024-02-12 | 2024-02-11 | LCTX | Samuel George A. III | GC, Sec | F - Tax | $1.08 | -2,490 | 7,184 | -26% | -$2,689 |
| I | 2024-02-08 | 2024-02-08 | LCTX | BAILEY DON M | Dir | P - Purchase | $1.04 | +96.2K | 158.8K | +153% | +$100.0K |
| I | 2024-02-08 | 2024-02-06 | LCTX | BROADWOOD PARTNERS, L.P. | Dir, 10% | P - Purchase | — | 0 | 41.67M | New | — |
| 2024-02-08 | 2024-02-06 | LCTX | BROADWOOD PARTNERS, L.P. | Dir, 10% | P - Purchase | $1.04 | +6.73M | 41.67M | +19% | +$7.00M | |
| 2024-01-02 | 2023-12-29 | LCTX | Jayasuriya Anula | Dir | P - Purchase | $1.09 | +10.0K | 10.0K | New | +$10.9K | |
| D | 2023-02-14 | 2023-02-11 | LCTX | Samuel George A. III | GC, Sec | M - OptEx | — | +6,076 | 6,076 | New | — |
| D | 2023-02-14 | 2023-02-11 | LCTX | Samuel George A. III | GC, Sec | F - Tax | $1.35 | -2,478 | 3,598 | -41% | -$3,345 |
| D | 2023-02-14 | 2023-02-11 | LCTX | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +31.2K | 139.1K | +29% | — |
| D | 2023-02-14 | 2023-02-11 | LCTX | Culley Brian M | Pres, CEO, Dir | F - Tax | $1.35 | -12.7K | 126.4K | -9% | -$17.2K |
| D | 2023-02-14 | 2023-02-11 | LCTX | Hogge Gary S. | SVP, Clinical, Medical Affairs | M - OptEx | — | +13.0K | 13.0K | New | — |
| D | 2023-02-14 | 2023-02-11 | LCTX | Hogge Gary S. | SVP, Clinical, Medical Affairs | F - Tax | $1.35 | -5,310 | 7,710 | -41% | -$7,169 |
| D | 2022-06-30 | 2022-06-30 | LCTX | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +15.4K | 113.2K | +16% | — |
| D | 2022-06-30 | 2022-06-30 | LCTX | Culley Brian M | Pres, CEO, Dir | F - Tax | $1.58 | -5,343 | 107.9K | -5% | -$8,442 |
| D | 2022-04-04 | 2022-03-31 | LCTX | Culley Brian M | Pres, CEO, Dir | P - Purchase | $1.53 | +6,400 | 97.8K | +7% | +$9,792 |
| D | 2022-04-04 | 2022-03-31 | LCTX | Culley Brian M | Pres, CEO, Dir | F - Tax | $1.54 | -5,343 | 91.4K | -6% | -$8,228 |
| D | 2022-04-04 | 2022-03-31 | LCTX | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +15.4K | 96.7K | +19% | — |
| 2022-03-29 | 2022-03-28 | LCTX | Amin Dipti | Dir | P - Purchase | $1.63 | +35.0K | 35.0K | New | +$57.0K | |
| 2022-03-28 | 2022-03-25 | LCTX | Culley Brian M | Pres, CEO, Dir | P - Purchase | $1.38 | +5,250 | 81.3K | +7% | +$7,245 | |
| 2022-03-25 | 2022-03-24 | LCTX | Mulroy Michael H. | Dir | P - Purchase | $1.40 | +7,000 | 258.6K | +3% | +$9,800 | |
| M | 2022-03-25 | 2022-03-23+ | LCTX | BRADSHER NEAL C | Dir, 10% | P - Purchase | $1.42 | +930.1K | 34.94M | +3% | +$1.32M |
| MI | 2022-03-25 | 2022-03-23+ | LCTX | BRADSHER NEAL C | Dir, 10% | P - Purchase | — | 0 | 34.47M | New | — |
| D | 2022-01-03 | 2021-12-31 | LCTX | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +15.4K | 81.4K | +23% | — |
| D | 2022-01-03 | 2021-12-31 | LCTX | Culley Brian M | Pres, CEO, Dir | F - Tax | $2.45 | -5,343 | 76.0K | -7% | -$13.1K |
| DM | 2021-12-30 | 2021-12-28+ | LCTX | Hogge Gary S. | SVP, Clinical, Medical Affairs | M - OptEx | $1.42 | +510.8K | 530.0K | +2,661% | +$724.7K |
| DM | 2021-12-30 | 2021-12-28+ | LCTX | Hogge Gary S. | SVP, Clinical, Medical Affairs | S - Sale+OE | $2.45 | -539.3K | 0 | -100% | -$1.32M |
| D | 2021-10-12 | 2021-09-30 | LCTX | Culley Brian M | Pres, CEO, Dir | F - Tax | $2.52 | -5,343 | 65.9K | -7% | -$13.5K |
| D | 2021-10-12 | 2021-09-30 | LCTX | Culley Brian M | Pres, CEO, Dir | M - OptEx | — | +15.4K | 71.3K | +28% | — |
Purchase Sale Sale after option exercise All abbreviations